![]() |
Jim Weiss |
Healthcare marketing and communications network W2O Group today announced that it has rebranded under a new name, Real Chemistry.
The independent agency, in a statement, said the name change addresses the disruption facing the healthcare sector since the outbreak of the COVID-19 pandemic, an environment in which information and services are increasingly delivered via intelligent technologies and one where the patient wields more control than ever.
“Innovation in healthcare has never moved faster or been more important,” Real Chemistry founder and CEO Jim Weiss told O’Dwyer’s. “That is why this moment is about so much more than a new name or approach. It’s about how our ethos of action, our two decades of intentional evolution and our drive for constant improvement helped us create what we see as the real chemistry between people and the brands born to change their lives.”
The San Francisco-headquartered network, which was founded in 2001, is the number-one independent healthcare PR firm, according to O’Dwyer’s annual rankings, accounting for about $219 million in net fees in 2019.


Jim Weiss
To make sure that the messages an annual meeting is supposed to deliver connect with their audiences, focus on the big story behind the complex data.
It’s not enough to simply be a good storyteller. Communicators now need to be explainers—making a range of complex subjects understandable to consumers.
Building awareness is no longer enough. Marketing and communications must ensure that when buyers begin researching a category, the company is visible, credible and differentiated.
With AI facing blowback from many audiences, it is becoming increasingly important to make sure that the human side of your communications comes through.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.



